Sort   by:  
 Page size 
UnknownObinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study.
Not available
S-EPMC9719965 | biostudies-literature
UnknownThe combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.
Not available
S-EPMC6738078 | biostudies-literature
UnknownImmunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients.
Not available
S-EPMC6011245 | biostudies-literature
UnknownDifferent prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.
Not available
S-EPMC9898037 | biostudies-literature
UnknownEfficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group.
Not available
S-EPMC8451799 | biostudies-literature
UnknownCAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders.
Not available
S-EPMC10815907 | biostudies-literature
UnknownCytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Not available
S-EPMC6509568 | biostudies-literature
UnknownATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.
Not available
S-EPMC12208880 | biostudies-literature
UnknownRichter transformation in diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia receiving ibrutinib: risk factors and outcomes.
Not available
S-EPMC12310524 | biostudies-literature
UnknownRefined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile.
Not available
S-EPMC5898432 | biostudies-literature
Sort   by:  
 Page size